CNTX – context therapeutics inc. (US:NASDAQ)
Stock Stats
News
Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results [Yahoo! Finance]
Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Context Therapeutics to Participate in Upcoming Investor Conferences in November
Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Context Therapeutics Inc. (NASDAQ: CNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Form EFFECT Context Therapeutics
Form SC 13G/A Context Therapeutics Filed by: Avidity Partners Management LP
Form SC 13G Context Therapeutics Filed by: Blue Owl Capital Holdings LP
Form SC 13G/A Context Therapeutics Filed by: GREAT POINT PARTNERS LLC
Form SC 13G/A Context Therapeutics Filed by: Hudson Bay Capital Management LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.